Hypermetabolic subcutaneous fat in patients on highly active anti-retroviral therapy treatment: Subtle finding with implications
A 34-year-old gentleman, on anti-retroviral therapy since 3 years was treated for lymphoblastic lymphoma. He was referred for fluorine-18 FDG positron emission tomography/computed tomography (PET/CT) study for follow-up evaluation. The scan revealed hypermetabolism in the mid thorax corresponding to esophageal candidiasis []. With a history of HAART therapy of 3 years duration, the scintigraphic findings of increased FDG uptake in the subcutaneous adipose tissue was suggestive of LD. He was treated with antifungal medications. To arrest the progression of LD, stavudine was replaced by tenofovir and diet modification was advised.